News

Researchers report the discovery that a protein called “Runx3” programs killer T cells to establish residence in tumors and infection sites.

“This drug candidate is poised to go into clinical trials, and we think it might be effective against multiple forms of autism."

"The success of ozanimod shows that academia and the NIH can make transforming discoveries that benefit patients and those that care for them."

Scientists at Scripps Research have discovered a compound that in laboratory tests irreversibly stops the growth of certain aggressive, treatment-resistant tumor cells.

"It’s certainly plausible that such compounds were present on the early Earth and played a role in the emergence of the complex molecules of life."

Bacterial growth on medical devices—such as artificial hip implants, knee implants and catheters—are a major threat to patient health.

The new study shows exactly why egg-based manufacturing is a problem for the H3N2 influenza subtype.

MyGeneRank app allows individuals with genetic data from 23andMe to obtain an estimated genetic risk score for coronary artery disease.

“Our new ADCs are built something like a double-decker bus..."

Scientists have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells.

Election to the Academy is considered one of the highest honors in the fields of health and medicine.

"Because of our aging population, these kinds of therapeutics are in great demand..."

A fascinating new look at fruit fly behavior.

Chemists at Scripps Research have demonstrated that they can repurpose DNA to create new substances with possible medical applications.

The center includes scientists from both the California and Florida campuses of Scripps Research.

Informatics experts at Scripps Research have been awarded close to $3 million as part of a five-year cooperative agreement to launch the National Center for Data to Health (CD2H).

"This new approach shows promise for identifying previously unrecognized ‘druggable’ targets in cancers that lack effective treatments."

The insights could help researchers design new drugs with better efficacy and fewer side effects.

A team of researchers from Scripps Research and Janssen Pharmaceuticals has devised artificial peptide molecules that neutralize a broad range of influenza virus strains.

A new peptide probe may hold the key to better understanding amyloid diseases.

Patrick R. Griffin, co-chair of the Department of Molecular Medicine on the Florida campus of Scripps Research, has been awarded a $2.5 million collaborative grant with Brigham and Women’s Hospital.

"Matt’s scientific contributions and business leadership played an important role in establishing Calibr and creating the new model for translational research and innovation represented by the affiliation with TSRI."

Sugar molecules on HIV envelope protein are likely target for future candidate vaccines.

Scientists at Scripps Research have found a new approach to the “reprogramming” of ordinary adult cells into stem cells.